FDA bans 15 toxic chemicals from cosmetics, lets states go stricter
H.R. 4433 — Toxic-Free Beauty Act of 2025 · Filed by Jan Schakowsky (D-IL) · 16 cosponsors · Introduced Jul 16, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill bans 15 specific chemicals and three categories of contaminants from cosmetic products sold in the U.S., effective January 1, 2027. It targets known or suspected hazards like formaldehyde, mercury, certain parabens, and heavy metals, while allowing states to maintain or adopt their own stricter rules. Cosmetic manufacturers will need to reformulate products containing these substances; consumers will have access to cosmetics without these ingredients.
Why we flagged it
The bill's operative mechanism is a straightforward ban on named hazardous chemicals in cosmetics, enforced through FDA authority under the Federal Food, Drug, and Cosmetic Act. It is a direct public-health restriction on product ingredients, not a subsidy, immunity grant, or industry carve-out.
What the text implies
- The 18-month effective date (January 1, 2027) may create a compliance cliff for manufacturers; products already in inventory or in final stages of production may face disposal or reformulation costs, which could be passed to consumers in the short term.
- The non-preemption clause explicitly preserves state authority to ban the same substances or set stricter limits, potentially creating a patchwork of state-level rules that manufacturers must navigate—increasing compliance complexity but also preventing federal preemption of stronger protections.
- The bill defines 'contaminants' as unintentional byproducts of manufacturing; setting detection limits (2 ppm for 1,4-dioxane and lead in general cosmetics, 5 ppm for lead in color cosmetics) may require manufacturers to invest in testing and purification infrastructure, raising barriers to entry for smaller producers.
- The list of banned substances is specific and named; future hazardous chemicals not on the list (e.g., emerging PFAS or other endocrine disruptors) would require new legislation to ban, creating a lag between scientific evidence and regulatory action.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill restricts manufacturers' ability to use chemicals linked to health concerns (formaldehyde, mercury, lead, asbestos) and preserves state authority to set stricter standards, expanding consumer protections without creating new private exemptions or liability shields. The 18-month implementation window allows industry adjustment without imposing sudden compliance costs on consumers.
Who stands to gain
- cosmetic manufacturers with existing formulations free of banned substances
- suppliers of alternative preservatives and ingredients
- testing and compliance consulting firms
Named in the bill
FDA, Federal Food, Drug, and Cosmetic Act, Section 601, Section 604, Section 614, Modernization of Cosmetics Regulation Act of 2022, state and local governments, cosmetic manufacturers
Where it stands
16 cosponsors: 16 Democrats.
- Jul 16, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jul 16, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $140,000 in lobbying spend. A filing names 11 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Jan Schakowsky, the sponsor, reported $88,051 in PAC receipts in the 2026 cycle.
- Personal Care Products Council — $140,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (4,632 characters) on Aug 18, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“FDA bans 15 toxic chemicals from cosmetics, lets states go stricter” QuorumCivic. https://share.quorumcivic.app/bill/119/hr4433 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.